Journal of Enzyme Inhibition and Medicinal Chemistry (Dec 2024)

Suppression of lipopolysaccharide-induced COX-2 expression via p38MAPK, JNK, and C/EBPβ phosphorylation inhibition by furomagydarin A, a benzofuran glycoside from Magydaris pastinacea

  • Shiu-Wen Huang,
  • Ming Jen Hsu,
  • Hsiu-Chen Chen,
  • Rita Meleddu,
  • Simona Distinto,
  • Elias Maccioni,
  • Filippo Cottiglia

DOI
https://doi.org/10.1080/14756366.2023.2287420
Journal volume & issue
Vol. 39, no. 1

Abstract

Read online

AbstractThe phytochemical investigation of the methanol extract of the seeds of Magydaris pastinacea afforded two undescribed benzofuran glycosides, furomagydarins A-B (1, 2), together with three known coumarins. The structures of the new isolates were elucidated after extensive 1D and 2D NMR experiments as well as HR MS. Compound 1 was able to inhibit the COX-2 expression in RAW264.7 macrophages exposed to lipopolysaccharide, a pro-inflammatory stimulus. RT-qPCR and luciferase reporter assays suggested that compound 1 reduces COX-2 expression at the transcriptional level. Further studies highlighted the capability of compound 1 to suppress the LPS-induced p38MAPK, JNK, and C/EBPβ phosphorylation, leading to COX-2 down-regulation in RAW264.7 macrophages.

Keywords